Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies have?
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies published?
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies has 2023 year in the ScholarIQ index.
What is the open-access status of Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies?
Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies has gold oa status in the ScholarIQ index.
What is the DOI of Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies?
The DOI for Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies is on the source record.
What is the PMID of Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies?
The PMID for Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies is on the source record.
What is the OpenAlex record for Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies?
The OpenAlex for Liver fibrosis and MAFLD: the exploration of multi-drug combination therapy strategies is on the source record.